Back to search

University of Leeds

Cell death mechanisms in human endogenous cardiac progenitor cells due to receptor tyrosine kinase inhibitor toxicity

Abstract

dc:description.abstract

The development of receptor tyrosine kinase inhibitors as anti-cancer drugs has improved patient prognosis, however they have also been linked to cardiotoxic side-effects. The impact of receptor tyrosine kinase inhibitors on human endogenous cardiac progenitor cells could have long-term impacts on myocardial ability to repair itself after damage. To study these toxic effects on cardiac progenitor cells, we isolated these cells from human right atrial appendage samples by immunomagnetic cell sorting, to obtain c-Kit-positive, CD45-negative cells. Cells were characterised and maintained in vitro, then imatinib, sunitinib or sorafenib was applied at concentrations equivalent to peak or trough plasma levels. Impact on cardiac progenitor cells viability and activation of cell death pathway mechanisms were investigated by: viability assay (fluorescein diacetate) and live cell staining to identify apoptotic or alternative cell death pathway activation. Further reverse transcription qPCR analyses of apoptosis, Western blotting, immunocytochemistry and calcium imaging provided a broad screen of underlying mechanisms and possible therapeutic targets.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Walmsley, Robert
Advisors dc:contributor.advisor
  • Smith, Andrew
  • Steele, Derek
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Walmsley, Robert. Cell death mechanisms in human endogenous cardiac progenitor cells due to receptor tyrosine kinase inhibitor toxicity. doctoral thesis, University of Leeds, 2020.